Trademark Overview
On Tuesday, April 22, 2025, a trademark application was filed for VIVOXYL with the United States Patent and Trademark Office. The USPTO has given the VIVOXYL trademark a serial number of 99148564. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 22, 2025. This trademark is owned by Khondrion IP B.V.. The VIVOXYL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of mitochondrial diseases, namely, primary and secondary mitochondrial diseases; Pharmaceutical preparations for the treatment of diseases and conditions with mitochondrial dysfunction, namely, altered redox status, increased reactive oxygen species, and inflammation